Bacterial concentrations in pus and infected peritoneal fluid - Implications for bactericidal activity of antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 2, 1998, Pages 227-232

  König, Christiane ^a   Simmen, Hans Peter ^a   Blaser, Jürg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; COLONY FORMING UNIT; ESCHERICHIA COLI; HUMAN; NONHUMAN; PERITONEAL FLUID; PUS; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS;

EID: 0031849123     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.2.227     Document Type: Article

References (22)

1. 2 incubation on MICs of macrolides? In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996, Poster D38, p. 67. American Society for Microbiology, Washington, DC.
2. 2 on the activity of antimicrobial agents in vitro. European Journal of Clinical Microbiology and Infectious Diseases 12, 519-26.
3. Malanoski, G. J., Eliopoulos, G. M., Ferraro, M. J. & Moellering, R. C. (1993). Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. European Journal of Clinical Microbiology and Infectious Diseases 12, 131-3.
4. Brook, I. (1989). Inoculum effect. Reviews of Infectious Diseases 11, 361-8.
5. Davey, P. G. & Barza, M. (1987). The inoculum effect with Gram-negative bacteria in vitro and in vivo. Journal of Antimicrobial Chemotherapy 20, 639-44.
6. Soriano, F., Ponte, C., Santamaria, M. & Jimenez Arriero, M. (1990). Relevance of the inoculum effect of antibiotics in the outcome of experimental infections caused by Escherichia coli. Journal of Antimicrobial Chemotherapy 25, 621-7.
7. Isenberg, H. D. & D'Amato, R. F. (1991). Indigenous and pathogenic microorganisms of humans. In Manual of Clinical Microbiology, 5th edn (Balows, A., Hausler, W. J., Herrmann, K. L., Isenberg, H. D. & Shadomy, H. J., Eds), pp. 2-14. American Society for Microbiology, Washington, DC.
8. Stamm, W. E. (1992). Approach to the patient with urinary tract infection. In Infectious Diseases (Gorbach, S. L., Bartlett, J. G. & Blacklow, N. R., Eds), pp. 788-98. WB Saunders, Philadelphia, PA.
9. Chastre, J., Fagon, J. Y., Bornet Lecso, M., Calvat, S., Dombret, M. C., al Khani, R. et al. (1995). Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. American Journal of Respiratory and Critical Care Medicine 152, 231-40.
10. Eagle, H. & Musselman, A. D. (1948). The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. Journal of Experimental Medicine 88, 99-131.
11. Holm, S. E., Tornqvist, I. O. & Cars, O. (1990). Paradoxical effects of antibiotics. Scandinavian Journal of Infectious Diseases - Suppl. 74, 113-7.
12. Entenza, J. M., Fluckiger, U., Glauser, M. P. & Moreillon, P. (1994). Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Journal of Infectious Diseases 170, 100-9.
13. Baddour, L. M., Lowrance, C., Albus, A., Lowrance, J. H., Anderson, S. K. & Lee, J. C. (1992). Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. Journal of Infectious Diseases 165, 749-53.
14. Gavalda, J., Cardona, P. J., Almirante, B., Capdevila, J. A., Laguarda, M., Pou, L. et al. (1996). Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrobial Agents and Chemotherapy 40, 173-8.
15. Bugnon, D., Potel, G., Xiong, Y. Q., Caillon, J., Kergueris, M. F., Le Conte, P. et al. (1996). In-vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model. Antimicrobial Agents and Chemotherapy 40, 1164-9.
16. Fantin, B., Pangon, B., Potel, G., Vallois, J. M., Caron, F., Bure, A. et al. (1989). Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Antimicrobial Agents and Chemotherapy 33, 767-70.
17. Davey, P., Barza, M. & Stuart, M. (1988). Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo. Journal of Antimicrobial Chemotherapy 21, 395-404.
18. Roosendaal, R., Bakker Woudenberg, I. A., van den Berghevan Raffe, M., Vink-van den Berg, J. C. & Michel, M. F. (1987). Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats. Antimicrobial Agents and Chemotherapy 31, 1809-15.
19. Gerber, A. U., Kozak, S., Segessenmann, C., Fluckiger, U., Bangerter, T. & Greter, U. (1989). Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model. European Journal of Clinical Microbiology and Infectious Diseases 8, 233-7.
20. Joiner, K., Lowe, B., Dzink, J. & Bartlett, J. G. (1982). Comparative efficacy of 10 antimicrobial agents in experimental infections with Bacteroides fragilis. Journal of Infectious Diseases 145, 561-8.
21. Brook, I. (1981). Aerobic and anaerobic bacteriology of cholesteatoma. Laryngoscope 91, 250-3.
22. Bilton, D., Pye, A., Johnson, M. M., Mitchell, J. L., Dodd, M., Webb, A. K. et al. (1995). The isolation and characterization of non-typeable Haemophilus influenzae from the sputum of adult cystic fibrosis patients. European Respiratory Journal 8, 948-53.